| Members |
targetComponentId |
| Morphine sulfate 75mg rectal tampon (product) |
Morphine sulfate 75 mg rectal suppository |
| Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg m/r capsule (product) |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule (product) |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 80mg m/r capsule (product) |
Product containing only morphine in oral dose form (medicinal product form) |
| Morphine sulfate 80mg prolonged-release oral capsule |
Product containing only morphine in oral dose form (medicinal product form) |
| Morphine tartrate+cyclizine (product) |
Product containing cyclizine and morphine (medicinal product) |
| Morphinian antitussive agent (substance) |
Morphinan opioid |
| Mosquito-borne bunyavirus encephalitis |
Mosquito-borne orthobunyavirus encephalitis |
| Mosquito-borne bunyavirus fever |
Mosquito-borne orthobunyavirus fever |
| Mother currently breast-feeding |
Mother currently breastfeeding |
| Mouse mammary tumor virus |
Mouse mammary tumour virus |
| Moxifloxacin hydrochloride (product) |
Product containing moxifloxacin (medicinal product) |
| Moxifloxacin hydrochloride 0.5% ophthalmic solution (product) |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Moxifloxacin hydrochloride 1.6mg/mL infusion solution 250mL bag (product) |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
| Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy |
| Mucinous cystic tumor with moderate dysplasia |
Mucinous cystadenoma |
| Mucoid otitis media |
Chronic mucoid otitis media |
| Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
| Mucositis following chemotherapy |
inflammation d'une membrane muqueuse à la suite d'une chimiothérapie (trouble) |
| Mulberry molar |
Moon's molar teeth |
| Mullet - dietary |
Mullet (substance) |
| Multiceps (organism) |
Taenia |
| Multiceps |
Taenia |
| Multiceps brauni |
Taenia brauni (organism) |
| Multiceps serialis |
Taenia serialis |
| Multicystic kidney |
Multicystic renal dysplasia |
| Multiple V-Y plasties |
Reconstruction of skin using local V-Y advancement flap (procedure) |
| Multiple closed fractures of skull and face with intracranial injury of other and unspecified nature (disorder) |
Injury of head |
| Multiple closed fractures of skull and face with other and unspecified intracranial hemorrhage (disorder) |
Injury of head |
| Multiple complications due to diabetes mellitus |
complication du diabète |
| Multiple complications due to type 1 diabetes mellitus (disorder) |
Disorder due to type 1 diabetes mellitus |
| Multiple endocrine deficiency syndrome, NEC |
Multiple endocrine deficiency syndrome |
| Multiple myeloma |
Multiple myeloma |
| Multiple myeloma, no International Classification of Diseases for Oncology subtype (morphologic abnormality) |
Plasma cell myeloma |
| Multiple non-ossifying fibromatosis (disorder) |
Neurofibromatosis type 1 |
| Multiple open fractures of skull and face with intracranial injury of other and unspecified nature (disorder) |
Injury of head |
| Multiple open fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
| Multiple-level cervical spondylosis with myelopathy |
Myelopathy due to multiple-level cervical spondylosis (disorder) |
| Multiple-level cervical spondylosis with radiculopathy |
Radiculopathy due to multiple-level cervical spondylosis |
| Mumps with other specified complication (disorder) |
Mumps with complication |
| MMR not given |
Measles mumps and rubella vaccination not done (situation) |
| Mupirocin calcium 2% cream (product) |
Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
| Mural cardiac aneurysm (& [other]) (disorder) |
Aneurysm of heart |
| Mural cardiac aneurysm |
Aneurysm of heart |
| Muscle bridge |
Reconstruction using flap (procedure) |
| Muscle transfer for claw toe repair |
Transfer of flexor to extensor tendon of lesser toe |
| Muscular calcification (disorder) |
Muscular ossification |
| Muscular wasting and disuse atrophy, NEC (disorder) |
Muscle atrophy |
| Musculoskel X-ray abnorm [D] |
X-ray of musculoskeletal system abnormal |
| Mushroom (organism) |
Order Agaricales (organism) |
| Mushroom - dietary |
Mushroom (substance) |
| Mustard - dietary |
Mustard seasoning (substance) |
| Mutase |
Mutase |
| Mycobacterium aquae (organism) |
Mycobacterium gordonae |
| Mycobacterium bolletii (organism) |
Mycobacteroides abscessus subspecies abscessus (organism) |
| Mycobacterium chelonae ss. abscessus |
Mycobacterium abscessus |
| Mycobacterium chlorophenolicus (organism) |
Mycobacterium chlorophenolicum |
| Mycobacterium margeritense |
Mycobacterium mageritense (organism) |
| Mycobacterium, MAIS group (organism) |
Mycobacterium, avium-intracellulare group (organism) |
| Mycophenolic acid 180mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet |
| Mycophenolic acid 360mg m/r capsule (product) |
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet |
| Product containing mycophenolate mofetil (medicinal product) |
Product containing mycophenolic acid (medicinal product) |
| Mycoplana bullata |
Brevundimonas bullata (organism) |
| Mycoplasma ellychniae |
Entomoplasma ellychniae |
| Mycoplasma lactucae |
Mesoplasma lactucae |
| Mycoplasma lepcaptivus |
Mycoplasma leonicaptivi (organism) |
| Mycoplasma lucivorax |
Entomoplasma lucivorax |
| Mycoplasma melaleucae |
Entomoplasma melaleucae |
| Mycoplasma somnilux |
Entomoplasma somnilux |
| Mycoplasma weynonii (organism) |
Mycoplasma wenyonii (organism) |
| Mycosis leptothrica |
Tonsillitis due to Gram negative bacteria |
| Mycotic aneurysm due to bacterial endocarditis (disorder) |
Endocarditis with infective aneurysm |
| Myelodysplasia (disorder) |
Myelodysplasia of spinal cord |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia (disorder) |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia |
| Myeloid leukemia (category) |
Myeloid leukaemia |
| Myeloid leukemia |
Myeloid leukaemia |
| Myeloproliferative disease |
Myeloproliferative disorder (morphologic abnormality) |
| Myelosclerosis |
myélofibrose |
| Myelosclerosis with myeloid metaplasia (morphologic abnormality) |
Myelosclerosis with myeloid metaplasia |
| Myocardial infarction clinical management plan (qualifier value) |
Myocardial infarction clinical management plan (record artifact) |
| Myoma |
Myoma |
| Myotenontoplasty (procedure) |
Myotenoplasty |
| Myotenoplasty of hand (procedure) |
Myotenoplasty |
| Myotension technique (procedure) |
Muscle energy technique (procedure) |
| Myovirus group |
Family Myoviridae (organism) |
| N0 category (finding) |
American Joint Committee on Cancer cN0 (qualifier value) |
| N1: Metastasis in 1-3 lymph nodes (finding) |
cN1 |
| N1: Metastasis in 1-6 perigastric lymph nodes (finding) |
cN1 |
| N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension (finding) |
cN1 |
| N1: Metastasis in a single lymph node (finding) |
cN1 |
| N1: Metastasis in a single lymph node, < 2 cm in greatest dimension (finding) |
cN1 |
| N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension (finding) |
cN1 |
| N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor (finding) |
cN1 |
| N1: Metastasis in perirectal lymph node or nodes |
cN1 |
| N1: Metastasis in regional lymph node or nodes (finding) |
cN1 |
| N1: Metastasis to movable ipsilateral axillary lymph node(s) (finding) |
cN1 |
| N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension (finding) |
cN1 |
| N1: Pelvic or inguinal lymph node metastasis (finding) |
cN1 |
| N1: Regional lymph node metastasis (finding) |
cN1 |
| N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa (finding) |
cN1 |
FHIR